The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

Cardiovascular medicine videos

Cardio-oncology in practice: bridging hospital & community – top tips for generalists

The increasing toxicity profile of cancer treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Dr SivaTharshini Ramalingam discuss how hospitals and community practitioners can work together to identify, treat and improve the quality of life for people experiencing cardiac dysfunction as a consequence of cancer treatments. She also explains which drugs are most commonly used, their key toxicities and reg flags for care.

Digital transformations in cardiovascular medicine – where do we begin?

Dr Sarah Hudson and Charles Lowe discuss the latest advancements in digital innovation both supporting and challenging cardiology clinicians in the UK. Topol Fellow, Dr Hudson shares her wealth of knowledge and experience as a cardiologist with Charles Lowe, who’s worked in the digital healthcare space for over 25 years. In this fascinating conversation, we discover what is happening in cardiology clinics and what the future might hold for cardiologists. Look out for future videos covering these topics in more detail:

Urgent reversal of anticoagulants – lessons for practice

In recent years, there has been a switch to direct oral anticoagulants (DOACs) as first-line thrombosis prevention, with fewer people started on a vitamin K antagonist, such as warfarin. This has led to an increase in number of people taking anticoagulants and, therefore, an increased risk of intracranial and intracerebral haemorrhages and gastrointestinal bleeds. Listen to Richard Buka, Clinical Research Fellow Institute of Cardiovascular Sciences at the University of Birmingham, discuss the challenges clinical teams face in the reversal of these drugs. He explores the findings of recent trials of Andexanet alfa and considers how effective these drugs really are and what it means in practice.

The evolving role of a Cardio-oncology Clinical Nurse Specialist

The increasing survival rate of cancer patients along with the increase in the toxicity profile of treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Priya Reehal, Clinical Nurse Specialist at the Royal Brompton Hospital Centre of Excellence for Cardio-oncology, discuss her role, present the findings of a decade-long study into the number of patients referred for cancer therapy–related cardiac dysfunction, and explain why we need more cardio-oncology centres of excellence across the UK.

Cardiac inflammation: the fire within

Federica Marelli-Berg takes a look at some common and not-so-common causes of myocarditis, and the clinical manifestations cardiologists should consider.

Transcatheter cardiac valves: An update in 2024

Jon Byrne and Madalina Garbi explore the latest guidelines and current practice around transcatheter valve interventions (including aortic valve implantation (TAVI), mitral regurgitation management and tricuspid valve repair) – which patients are suitable for these interventions, and how do they compare to traditional surgical approaches?

Key highlights from Heart Failure 2024 – Annual congress of the Heart Failure Association of the ESC

Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.